Natural history of COVID-19 and therapeutic options-Reference-Cited by-同舟云学术

Natural history of COVID-19 and therapeutic options

Published:2020-12-01 Issue:12 Volume:16 Page:1159-1184
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Gautret Philippe¹²,Million Matthieu¹³,Jarrot Pierre-André⁴,Camoin-Jau Laurence¹³⁵,Colson Philippe¹³,Fenollar Florence¹²,Leone Marc¹³⁶,La Scola Bernard¹³,Devaux Christian¹³⁷,Gaubert Jean Yves⁸,Mege Jean-Louis¹³,Vitte Joana¹³,Melenotte Cléa¹³,Rolain Jean-Marc¹³,Parola Philippe¹²,Lagier Jean-Christophe¹³,Brouqui Philippe¹³,Raoult Didier¹³

Affiliation:

1. Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France

2. Ird, Ap-hm, Ssa, Vitrome, Aix Marseille Univ, Marseille, France

3. Ird, Ap-hm, Mephi, Aix Marseille Univ, Marseille, France

4. Service De Médecine Interne, Hôpital De La Conception, APHM, France

5. Laboratoire d’Hématologie, Hôpital De La Timone, APHM, Boulevard Jean- Moulin, Marseille, France

6. Service d’Anesthésie Et De Réanimation, Hôpital Nord, APHM, Marseille, France

7. CNRS, Marseille, France

8. Department of Radiology and Cardiovascular Imaging, Aix Marseille Univ, LIIE, Marseille, France

Funder

Institut Hospitalo-Universitaire (IHU) Méditerranée Infection, the National Research Agency under the programme « Investissements d’avenir »

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2021.1847640

Reference210 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

2. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

3. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

4. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China

5. Quantifying additional COVID-19 symptoms will save lives

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Perpetual Impact of COVID-19 on the Geriatric Population's Quality of Life and Potential Preventive and Therapeutic Measures in Unani Medicine: An Evidence-based Review;Current Traditional Medicine;2024-06

2. Review on Diabetes Mellitus: An Insight into the Current Scenarios, the Challenges of Therapy, and Application of Traditional Drugs;Current Traditional Medicine;2024-06

3. A methodological showcase: utilizing minimal clinical parameters for early-stage mortality risk assessment in COVID-19-positive patients;PeerJ Computer Science;2024-04-30

4. Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2024-04-19

5. Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals;PLOS Global Public Health;2024-02-12